![logo](/logos/MAGLE.ST.webp)
Magle Chemoswed Holding AB (publ)
SSE:MAGLE.ST
27.6 (SEK) • At close February 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Magle Chemoswed Holding AB (publ) |
Symbool | MAGLE.ST |
Munteenheid | SEK |
Prijs | 27.6 |
Beurswaarde | 298,080,000 |
Dividendpercentage | 1.08% |
52-weken bereik | 21.4 - 38 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Hans Henrik Lidgard |
Website | https://www.maglechemoswed.com |
An error occurred while fetching data.
Over Magle Chemoswed Holding AB (publ)
Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)